Sarissa Biomedical

Sarissa Biomedical is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity/disorders.

Click here to view our full portfolio

Mercia Fund Management is an active investor in early-stage technology companies located in Central England.

Quick Contact

Registered in England No. 06973399. Registered Office: Wellington House, 31-34 Waterloo Street, Birmingham B2 5TJ.
Mercia Fund Management Limited is authorised and regulated by the Financial Services Authority in the conduct of its Investment Business.